understanding biosimilars: how the availability of biosimilars will impact clinical practice
Published 7 years ago • 137 plays • Length 35:31Download video MP4
Download video MP3
Similar videos
-
17:57
understanding biosimilars: differences between biosimilars and reference products
-
8:32
navigating biosimilars: implications for clinicians (red line)
-
0:50
navigating biosimilars: introduction
-
3:48
module 2: biosimilars—advances in research and development
-
6:43
biosimilars
-
6:02
the evolution of biotechnology – the arrival of biosimilars
-
7:57
biosimilar characterization
-
3:00
biosimilars: complex copycat drugs
-
38:15
biosimilars and biologics
-
8:03
navigating biosimilars: extrapolation, naming, substitution (blue line)
-
10:58
navigating biosimilars: us regulatory requirements (yellow line)
-
2:04
biosimilars: the path to approval
-
0:51
fast facts about extrapolation for biosimilars - amgen science
-
53:18
utilization of biosimilars: achieving value-based plan management
-
4:12
the basics of biosimilars
-
3:42:11
pharmacodynamic biomarkers for biosimilar development and approval: day 2
-
3:45
what are biosimilars? how do they work for arthritis?
-
13:32
01 introduction to biosimilars
-
1:15:43
biosimilars: full event
-
11:40
debate: biosimilar therapies - caution, more studies are needed
-
4:21
biosimilars - making the switch
-
51:57
pinpointing the top questions and considerations about biosimilars in gastroenterology